Skip to main content
. 2022 Jun 10;9(7):ofac286. doi: 10.1093/ofid/ofac286

Table 1.

Baseline Characteristics

All Patients (n = 80) Treatment (n = 43) Control (n = 37) P Value
Age, median (IQR), y 66 (56–72) 66 (55–72) 65 (56–71) .904
Male 54 (67.5) 29 (67.4) 25 (67.6) .990
Race .693
 White 30 (37.5) 16 (37.2) 14 (37.8)
 Other 30 (37.5) 15 (34.9) 13 (35.1)
 Asian 17 (21.3) 8 (18.6) 9 (24.3)
 African American 3 (3.8) 2 (4.7) 1 (2.7)
 Unknown 2 (2.5) 2 (4.7) 0
CCI, median (IQR) 4 (2–6) 4 (2–5) 4 (2–6) .329
Medical history
 DM 39 (48.8) 21 (48.8) 18 (48.6) .987
 MI 21 (26.3) 10 (23.3) 11 (29.7) .688
 Renal disease 15 (18.8) 7 (16.3) 8 (21.6) .747
 Smokinga 11 (13.8) 6 (14) 5 (13.5) .955
 Liver disease 10 (12.5) 5 (11.6) 5 (13.5) 1
 Asthma 9 (11.3) 3 (7.0) 6 (16.2) .290
 COPD 9 (11.3) 4 (9.3) 5 (13.5) .726
 Cancer 9 (11.3) 4 (9.3) 5 (13.5) .726
  Metastatic solid malignancy 1 (1.3) 0 1 (2.7) .462
 Cerebrovascular disease 8 (10) 4 (9.3) 4 (10.8) 1
 Pulm circ disordersb 6 (7.5) 1 (2.3) 5 (13.5) .09
 PVD 5 (6.3) 1 (2.3) 4 (10.8) .176
 CHF 2 (2.5) 1 (2.3) 1 (2.7) 1
Admission to ICU from ED 27 (33.8) 16 (37.2) 11 (29.7) .640
Time from admission to first CMV test, median (IQR), d 13 (8–29) 10 (8–22) 20 (11–35) .037
 Time from admission to CMV viremia, median (IQR), d 27 (18–39) 25 (18–38) 30 (20–42) .145
Time from ICU admission to first CMV test, median (IQR), d 22 (14–32) 7 (1–22) 13 (4–27) .086
 Time from ICU admission to CMV viremia, median (IQR), d 22 (14–32) 20 (12–32) 24 (15–32) .478
Time from MV to CMV pos (n = 70) 19 (11–32) 19 (10–33) n = 36 22 (11–31) n = 34 .672

All data are expressed as No. (%) unless otherwise specified.

Abbreviations: CCI, Charlson comorbidity index; CHF, congestive heart failure; CMV, cytomegalovirus; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; ED, emergency department; ICU, intensive care unit; IQR, interquartile range; MI, myocardial infarction; MV, mechanical ventilation; PVD, peripheral vascular disease.

a

Smoking status is unreliably documented in our computerized order entry system.

b

Pulm circ disorders includes pulmonary embolism, pulmonary heart diseases (ie, pulmonary hypertension), and diseases of pulmonary vessels.